Is there a right way to handle switching compounds on Tesamorelin

Two months into HGH and the lab work comes back with IGF-1 sitting at 159. Now the argument in your head kicks off: crank the HGH dose higher, or make the jump and start switching compounds, tesamorelin style? Short answer: don't cold-swap vials on a Monday and hope for the best. There is a smarter way to handle switching compounds on tesamorelin, and it starts with understanding why tesamorelin and HGH talk to your body in two completely different languages.

HGH And Tesamorelin Aren't The Same Lever

I've said this to clients for years: injecting HGH is straight external fuel. It bypasses your pituitary gland entirely and drops finished growth hormone right into your bloodstream. Your pituitary notices the tank is full and does what any smart system does: it STOPS making its own. That's negative feedback, and it isn't a design flaw. It's the brakes working exactly as designed.

Tesamorelin does something totally different. It's a modified copy of GHRH (growth-hormone-releasing hormone, the actual signal your brain sends when it wants your pituitary to make GH), engineered with a small chemical shield so the enzyme that normally chews up that signal in minutes can't touch it, and the shield genuinely works. Instead of refueling you from outside, tesamorelin taps your own pituitary on the shoulder and says go ahead, make your own. Different lever entirely.

Why does that matter for switching? Because if you go straight from HGH, which has spent two months telling your pituitary to sit down and relax, into tesamorelin, which needs that same pituitary to actually get up and pulse GH on its own, there can be a lag. Your engine doesn't restart INSTANTLY just because somebody handed it the keys back.

I'm a proud geek about this stuff, feedback loops fascinate me, but let's get practical about what your 159 actually means.

What That IGF-1 Number Is Actually Telling You

Here's the part nobody in the thread wants to hear: cranking your HGH dose higher to chase a number doesn't fix anything. It just pours more finished hormone into a system that's already telling you it's full. I like to call this symptomese, the language your body speaks in signals, and a lab value is just another dialect of it. An elevated IGF-1 is your body talking. It isn't a verdict.

Two pivotal Phase 3 trials on tesamorelin, run over 26 to 52 weeks in real patients, showed visceral fat dropping alongside a GH-axis effect that has a natural ceiling built into it. IGF-1 does climb on tesamorelin too, don't get me wrong, it's still working the GH axis. But because that climb runs through your own pituitary's pulse-and-brake system instead of a flat external dose, it tends to PLATEAU rather than run away on you. A 2026 meta-analysis pooling five RCTs even found lean mass went UP by about a kilo and a half while visceral and liver fat both dropped. Not bad for a compound some folks assume just spikes your numbers and walks away.

So the real question buried under "increase or switch" isn't dosing math. It's which lever you're pulling. More HGH is more of the same lever. Tesamorelin is a different lever, one with more built-in governance.

That said, crap advice is everywhere on this topic, and I'm not going to sit here and tell you tesamorelin is a magic reset button. Your IGF-1 doesn't come only from how much GH signal you're getting, it comes from what your liver does with that signal, and sleep, stress, and body composition all play into the conversion from GH to IGF-1. Nope. Tesamorelin won't cancel out a bad sleep schedule.

The Actual Right Way To Switch

Here's what I'd tell a friend at the gym, not a forum full of confident guesses. And here's the thing to remember before any of these steps: this is a marathon, not a sprint. Judging a switch off one number, one week in, is how people end up switching a third time for no good reason.

Step one, get a clean baseline. Don't switch the same week your IGF-1 comes back elevated. Retest in a few weeks first. Know your real trend before you touch anything.

Step two, taper instead of slamming the brakes. Cold-stopping HGH isn't dangerous the way stopping a blood pressure medication can be, but tapering down over a week or two gives your own pituitary a gentler on-ramp than asking it to go from zero to sixty overnight.

Step three, start tesamorelin at the studied dose and give it real time. The label dose behind those visceral-fat results in the pivotal trials was 2 mg a day.

Now the part my lawyer makes me say, and honestly he's right: The doses and schedules here are for educational and informational purposes only. These peptides are sold for research use only and are not FDA-approved drugs. This is not medical advice. Consult a qualified physician before beginning any protocol.

The real-world protocol most people actually run looks like this: a 10 mg vial reconstituted with 2 ml of bacteriostatic water gives you 1 mg per 20 units on a standard insulin syringe. Most run 1 mg in the morning and 1 mg at night, five days on, two off, for an 8-week block, then a break. Recheck IGF-1 at the 4 to 8 week mark, not week one. You want a TREND, not a snapshot.

Step four, don't chase the number, chase the direction it's moving. A single IGF-1 draw bounces around with time of day, recent training, even how you slept the night before. One 159 isn't a five-alarm fire. It's DATA, not diagnosis.

Slow down. Get how you're actually injecting dialed in before you worry about which vial is in the syringe, because sloppy technique muddies every lab result that comes after it.

I'll say this plainly because I see it constantly: people panic over one lab value and make a huge protocol decision off it. Read the full tesamorelin breakdown before you start anything. It covers the honest read on long-term IGF-1 monitoring in a lot more depth than one Reddit thread ever will.

Thanks for reading! In health, Rick Gold